Primary breast leiomyosarcoma and synchronous homolateral lung cancer: a case report
Alberto Testori(IRCCS Humanitas Research Hospital), Ugo Cioffi(University of Milan), Emanuele Voulaz(Humanitas University), Paola Bossi(IRCCS Humanitas Research Hospital), Stefano Meroni(European Institute of Oncology), Umberto Cariboni(IRCCS Humanitas Research Hospital), Marco Alloisio(IRCCS Humanitas Research Hospital), Matilde De Simone(University of Milan), Rita De Sanctis(Humanitas University)
Cited by 9
Related Papers
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial
|The Lancet Oncology|2017|493
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial
|The Lancet Neurology|2021|260
Functional changes in Duchenne muscular dystrophy
|Neurology|2011|178
Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1–2 Breast Cancer Patients Presenting One or Two Metastatic Sentinel Lymph Nodes: The SINODAR-ONE Multicenter Randomized Clinical Trial
|Annals of Surgical Oncology|2022|162
PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy
|European Journal of Nuclear Medicine and Molecular Imaging|2019|150